Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
14.96
+0.76 (5.35%)
Nov 5, 2024, 4:00 PM EST - Market closed
Axogen Employees
As of December 31, 2023, Axogen had 428 total employees, including 426 full-time and 2 part-time employees. The number of employees increased by 32 or 8.08% compared to the previous year.
Employees
428
Change (1Y)
32
Growth (1Y)
8.08%
Revenue / Employee
$405,332
Profits / Employee
-$38,640
Market Cap
655.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CureVac | 1,172 |
Revance Therapeutics | 597 |
Exscientia | 483 |
Entrada Therapeutics | 159 |
IRADIMED CORPORATION | 148 |
Alumis | 109 |
CorMedix | 83 |
Tectonic Therapeutic | 44 |
AXGN News
- 2 months ago - Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft® - GlobeNewsWire
- 3 months ago - Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Axogen, Inc. Announces New Leadership Appointments - GlobeNewsWire
- 3 months ago - Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 - GlobeNewsWire
- 4 months ago - Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 4 months ago - Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™ - GlobeNewsWire
- 5 months ago - Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia - GlobeNewsWire
- 6 months ago - AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript - Seeking Alpha